Home/Stock Check/MRNA
    AI Stock Check · The Money GPSUpdated Nov 20, 2026 · live

    Is Moderna (MRNA) a Buy Right Now?

    A plain-English read on Moderna stock — what the chart and the numbers are saying today, with no jargon and no hype.

    Signal lockedMembers see the Buy / Hold / Be Careful call on MRNA right here.
    Price
    $199.33
    Today
    +1.29%
    RSI (14)
    39
    MRNA · DailyLive interactive chart
    Drag to pan · scroll to zoom · hover for prices Unlock 26+ indicators, drawing tools & AI Read
    Members-only signal

    We've already run the numbers on MRNA.

    Our AI has a Buy, Hold or Be Careful call on Moderna right now — in plain English, why, the 4 factors moving it, and the bottom line. That's the part a beginner actually needs, and it's the one thing on this page we don't give away for free.

    Unlock the MRNA Signal

    Includes this signal plus the rest of the 37-tool platform. Cancel anytime — no contract.

    What Moderna actually does

    Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

    Industry · BiotechnologyHQ · Cambridge, MA, United StatesPublic since · 2018Market cap · $80.65B

    Moderna by the numbers

    Market cap$80.65B
    P/E (trailing)—
    P/E (forward)-47.6
    Price / sales31.9
    Price / book11.8
    Revenue growth (yoy)13.1%
    Earnings growth (yoy)—
    Profit margin-110.5%
    5-year average margin-42.4%
    Return on equity-37.6%
    Dividend yieldPays no dividend

    Wall Street consensus on MRNA is Hold. That is the analyst community's view, shown for context — it is not our read and not a recommendation.

    Has Moderna been beating expectations?

    Moderna beat Wall Street's earnings estimate in 4 of the last 4 reported quarters. Companies that consistently miss their own guidance tend to see sharper price reactions on results day.

    Recent reported earnings for MRNA
    Period endEPS reportedEstimateResult
    2026-09-300.38-1.25Beat +1.3%
    2026-06-30-1.97-2.06Beat +0.0%
    2026-03-31-3.40-3.88Beat +0.1%
    2025-12-31-2.11-2.60Beat +0.2%

    Who owns Moderna?

    Institutions — pension funds, asset managers, index providers — hold 77.5% of MRNA, and the concentration matters: the largest single holder alone controls 14.57% of the company.

    Institutional
    77.5%
    Top holder
    14.57%
    Top 6 combined
    40.67%
    HolderShares% held
    58.96M14.57%
    27.80M6.87%
    23.91M5.91%

    Names withheld — plus 3 more records not shown.

    See who owns it
    The Power Map names every reported holder, their share count and how the stake has changed, for MRNA and every other company in the suite.

    What Moderna insiders have been doing

    Executives and directors must disclose their own trades in company stock. Of the last 6 disclosed transactions we hold for Moderna, 2 were sales and 0 were open-market purchases; the other 4 were awards, vesting or option exercises rather than a decision to buy or sell. Insiders sell for many ordinary reasons — scheduled plans, tax, diversification — so a sale is not by itself a signal.

    Disclosed
    6
    Sales
    2
    Open-market buys
    0
    Value sold
    $16.4M
    InsiderDateTypeSharesValue
    2026-10-05AWARD / VEST1.5K—
    2026-09-15SELL80.6K$11.7M
    2026-09-15AWARD / VEST152.9K$1.9M

    Names withheld — plus 3 more records not shown.

    See which insiders
    Members see the name and role behind every Form 4, the full transaction history, and alerts when an insider files.

    The numbers behind the read

    Trend up · above its 200-day average
    Recent support / resistance$189.98 — $280.80
    52-week range$29.06 — $280.80

    Who in Washington has been trading MRNA?

    Members of Congress must disclose trades over $1,000 within 45 days under the STOCK Act. 11 disclosures name MRNA — filed by 6 separate members and worth $25K–$200K combined (filings report bands, never exact amounts). 3 purchase-side, 8 sale-side, most recently on 2026-10-20.

    Disclosures
    11
    Members
    6
    Bought / sold
    3 / 8
    Value filed
    $25K–$200K
    MemberDateActionAmount filed
    2026-10-20BUY$1,001 - $15,000
    2026-09-24SELL$1,001 - $15,000
    2026-08-19SELL$1,001 - $15,000

    Names withheld — plus 8 more records not shown.

    See which members
    A disclosure is a matter of public record, not evidence of wrongdoing and not a signal to trade. Members get the name, chamber, committee and full filing history behind every row — see the Congress trades tracker.

    Don't guess. Practice this trade first.

    Buy it with virtual cash and watch how it plays out — before a dollar of your own is on the line.

    Practice MRNA risk-free in your paper portfolio

    Paper trading, the AI Read & live indicators are inside a Money GPS membership — one price, the whole platform.

    Related checksIs JNJ a buy?Is PFE a buy?Is LLY a buy?Is UNH a buy?

    Important disclaimer

    This page is for educational and informational purposes only and is not financial, investment, tax, or legal advice, nor a recommendation, offer, or solicitation to buy, sell, or hold Moderna (MRNA) or any other security. The Money GPS is not a registered investment adviser, broker-dealer, or financial planner, and no content here should be relied upon to make an investment decision.

    The verdict, indicators, and commentary are generated automatically — in part using AI — from third-party market data (via Yahoo Finance) that may be delayed, incomplete, or inaccurate, and is provided “as is” without any warranty. Figures reflect the market as of 2026-11-19 and change constantly; the read above may already be out of date. A “Buy,” “Hold,” or “Be Careful” label is a simplified, rules-based signal for beginners — not a price target or a guarantee of any outcome.

    All investing involves risk, including the possible loss of your entire principal. Past performance and historical patterns do not guarantee future results. Always do your own research and consult a licensed financial professional who knows your personal circumstances before investing. You are solely responsible for your own investment decisions. The Money GPS and its authors may hold positions in the securities discussed and accept no liability for any loss arising from the use of this information.

    Political Trackers

    • Congress Stock Trades
    • Browse Congress by Name
    • Tommy Tuberville Stock Trades
    • Pelosi Trades
    • Trump Stock Trades
    • Trump Family Crypto
    • Barron Trump Portfolio
    • Melania Trump Portfolio
    • Eric Trump Portfolio
    • Don Jr. Portfolio
    • Government Stakes

    Market Tools

    • AI Stock Analyst
    • Advanced Charts
    • Market Signal Board
    • Macro Tracker
    • Smart Money Tracker
    • Supply Chain Explorer

    Research

    • Stock Check — All Tickers
    • Bitcoin Cycle GPS
    • Bitcoin Halving Cycle
    • Portfolio Stress Test
    • Inflation Calculator
    • Portfolio Protection

    Free & Company

    • How To Build a Portfolio
    • Compass — Free Course
    • Rewind — History Globe
    • Pricing & Access
    • About David Quintieri
    • Contact

    © 2026 The Money GPS. All rights reserved.

    ContactDisclaimerTermsPrivacy Policy

    The Money GPS provides educational and informational content only. Nothing on this site is financial, investment, tax, or legal advice, or a recommendation to buy or sell any security. All investing involves risk, including loss of principal.